Advertisement
Screener

Alaunos Therapeutics, Inc. (TCRT) Scorecard

2.8 / 5 stars · 68/120 Roast Me

Alaunos Therapeutics, Inc. (TCRT) Scorecard

  • 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
  • 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
40 QUARTERS × 3 ROAST BATTLES
19/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

QuarterTotal returnRevenue growthEPS growth
2026-Q20/3 LoseTCRT / S&P
-20.98% / 15.20% 		LoseTCRT / S&P
-50.00% / 15.00% 		LoseTCRT / S&P
-22.36% / 50.40%
2026-Q10/3 LoseTCRT / S&P
-11.46% / -4.33% 		LoseTCRT / S&P
-70.00% / 11.30% 		LoseTCRT / S&P
-16.14% / 27.70%
2025-Q41/3 WinTCRT / S&P
34.02% / 2.65% 		LoseTCRT / S&P
-44.44% / 9.00% 		LoseTCRT / S&P
-24.32% / 13.40%
2025-Q30/3 LoseTCRT / S&P
-50.31% / 8.12% 		LoseTCRT / S&P
0.00% / 4.61% 		LoseTCRT / S&P
-68.61% / 13.45%
2025-Q21/3 WinTCRT / S&P
229.93% / 10.94% 		LoseTCRT / S&P
0.00% / 4.83% 		LoseTCRT / S&P
-79.43% / 10.63%
2025-Q11/3 LoseTCRT / S&P
-23.04% / -4.27% 		WinTCRT / S&P
66.67% / 4.98% 		LoseTCRT / S&P
-84.83% / 10.57%
2024-Q41/3 LoseTCRT / S&P
-40.68% / 2.41% 		WinTCRT / S&P
80.00% / 5.25% 		LoseTCRT / S&P
-82.11% / 6.15%
2024-Q30/3 LoseTCRT / S&P
-54.00% / 5.89% 		LoseTCRT / S&P
-60.00% / 5.89% 		LoseTCRT / S&P
-47.05% / 6.11%
2024-Q21/3 LoseTCRT / S&P
-61.33% / 4.28% 		LoseTCRT / S&P
-99.79% / 5.38% 		WinTCRT / S&P
38.43% / 5.12%
2024-Q12/3 WinTCRT / S&P
72.38% / 10.56% 		LoseTCRT / S&P
-99.79% / 5.71% 		WinTCRT / S&P
423.13% / 5.59%
2023-Q41/3 LoseTCRT / S&P
-46.15% / 11.69% 		LoseTCRT / S&P
TCRT unavailable / 6.81% 		WinTCRT / S&P
522.90% / 7.78%
2023-Q31/3 LoseTCRT / S&P
-74.51% / -3.27% 		LoseTCRT / S&P
TCRT unavailable / 7.52% 		WinTCRT / S&P
6850.00% / -5.03%
2023-Q21/3 LoseTCRT / S&P
-19.05% / 8.74% 		LoseTCRT / S&P
TCRT unavailable / 9.50% 		WinTCRT / S&P
3100.00% / -8.57%
2023-Q11/3 LoseTCRT / S&P
-3.08% / 7.50% 		LoseTCRT / S&P
TCRT unavailable / 10.77% 		WinTCRT / S&P
869.70% / -15.69%
2022-Q40/3 LoseTCRT / S&P
-62.21% / 7.56% 		LoseTCRT / S&P
TCRT unavailable / 11.88% 		LoseTCRT / S&P
TCRT unavailable / -17.99%
2022-Q31/3 WinTCRT / S&P
38.71% / -4.88% 		LoseTCRT / S&P
TCRT unavailable / 13.47% 		LoseTCRT / S&P
TCRT unavailable / -1.41%
2022-Q21/3 WinTCRT / S&P
90.77% / -16.10% 		LoseTCRT / S&P
TCRT unavailable / 13.71% 		LoseTCRT / S&P
TCRT unavailable / 11.04%
2022-Q10/3 LoseTCRT / S&P
-40.37% / -4.60% 		LoseTCRT / S&P
TCRT unavailable / 15.97% 		LoseTCRT / S&P
TCRT unavailable / 42.23%
2021-Q40/3 LoseTCRT / S&P
-40.11% / 11.03% 		LoseTCRT / S&P
TCRT unavailable / 15.00% 		LoseTCRT / S&P
TCRT unavailable / 96.40%
2021-Q30/3 LoseTCRT / S&P
-31.06% / 0.58% 		LoseTCRT / S&P
TCRT unavailable / 10.77% 		LoseTCRT / S&P
TCRT unavailable / 69.42%
2021-Q20/3 LoseTCRT / S&P
-26.67% / 8.55% 		LoseTCRT / S&P
TCRT unavailable / 6.58% 		LoseTCRT / S&P
TCRT unavailable / 51.81%
2021-Q11/3 WinTCRT / S&P
42.86% / 6.17% 		LoseTCRT / S&P
TCRT unavailable / -1.06% 		LoseTCRT / S&P
TCRT unavailable / 7.39%
2020-Q40/3 LoseTCRT / S&P
0.00% / 12.15% 		LoseTCRT / S&P
TCRT unavailable / -3.72% 		LoseTCRT / S&P
TCRT unavailable / -33.42%
2020-Q30/3 LoseTCRT / S&P
-23.17% / 8.93% 		LoseTCRT / S&P
TCRT unavailable / -2.04% 		LoseTCRT / S&P
TCRT unavailable / -27.10%
2020-Q21/3 WinTCRT / S&P
33.88% / 20.54% 		LoseTCRT / S&P
TCRT unavailable / -0.46% 		LoseTCRT / S&P
TCRT unavailable / -27.11%
2020-Q10/3 LoseTCRT / S&P
-48.09% / -19.60% 		LoseTCRT / S&P
TCRT unavailable / 3.47% 		LoseTCRT / S&P
TCRT unavailable / -14.75%
2019-Q41/3 WinTCRT / S&P
10.28% / 9.07% 		LoseTCRT / S&P
TCRT unavailable / 5.36% 		LoseTCRT / S&P
TCRT unavailable / 2.99%
2019-Q30/3 LoseTCRT / S&P
-26.59% / 1.70% 		LoseTCRT / S&P
TCRT unavailable / 5.02% 		LoseTCRT / S&P
TCRT unavailable / 0.21%
2019-Q21/3 WinTCRT / S&P
51.43% / 4.30% 		LoseTCRT / S&P
TCRT unavailable / 6.64% 		LoseTCRT / S&P
TCRT unavailable / 8.65%
2019-Q11/3 WinTCRT / S&P
105.88% / 13.65% 		LoseTCRT / S&P
TCRT unavailable / 8.12% 		LoseTCRT / S&P
TCRT unavailable / 14.29%
2018-Q40/3 LoseTCRT / S&P
-41.56% / -13.52% 		LoseTCRT / S&P
TCRT unavailable / 9.05% 		LoseTCRT / S&P
TCRT unavailable / 18.23%
2018-Q30/3 LoseTCRT / S&P
5.96% / 7.71% 		LoseTCRT / S&P
TCRT unavailable / 10.21% 		LoseTCRT / S&P
TCRT unavailable / 19.06%
2018-Q20/3 LoseTCRT / S&P
-22.96% / 3.43% 		LoseTCRT / S&P
TCRT unavailable / 9.03% 		LoseTCRT / S&P
TCRT unavailable / 14.46%
2018-Q10/3 LoseTCRT / S&P
-5.31% / -0.76% 		LoseTCRT / S&P
TCRT unavailable / 7.68% 		LoseTCRT / S&P
TCRT unavailable / 12.46%
2017-Q40/3 LoseTCRT / S&P
-32.57% / 6.64% 		LoseTCRT / S&P
TCRT unavailable / 7.03% 		LoseTCRT / S&P
TCRT unavailable / 13.82%
2017-Q30/3 LoseTCRT / S&P
-1.29% / 4.48% 		LoseTCRT / S&P
TCRT unavailable / 5.68% 		LoseTCRT / S&P
TCRT unavailable / 17.57%
2017-Q20/3 LoseTCRT / S&P
-1.89% / 3.09% 		LoseTCRT / S&P
TCRT unavailable / 4.83% 		LoseTCRT / S&P
TCRT unavailable / 17.74%
2017-Q11/3 WinTCRT / S&P
18.50% / 6.07% 		LoseTCRT / S&P
TCRT unavailable / 3.67% 		LoseTCRT / S&P
TCRT unavailable / 13.32%
2016-Q40/3 LoseTCRT / S&P
-4.97% / 3.82% 		LoseTCRT / S&P
TCRT unavailable / 2.09% 		LoseTCRT / S&P
TCRT unavailable / 7.05%
2016-Q30/3 LoseTCRT / S&P
2.55% / 3.85% 		LoseTCRT / S&P
TCRT unavailable / 0.20% 		LoseTCRT / S&P
TCRT unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

MetricTCRT total returnS&P 500 Total Return Index
Total return-22.07%20.78%
Annualized return-22.07%20.78%

5Y · 2021-09-01 to 2026-08-27

MetricTCRT total returnS&P 500 Total Return Index
Total return-99.38%83.14%
Annualized return-63.84%12.86%

10Y · 2016-09-01 to 2026-08-27

MetricTCRT total returnS&P 500 Total Return Index
Total return-99.78%319.30%
Annualized return-45.73%15.41%

Calculation rules

window
Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis
Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule
Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency
Quarter endpoints only.
fundamentals
Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Genprex, Inc. (GNPX)United States$0.003B-0.02
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
GeoVax Labs, Inc. (GOVX)United States$0.003B-0.45
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
Sunshine Biopharma Inc. (SBFM)$0.003B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Aptevo Therapeutics Inc. (APVO)United States$0.003B
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
Advertisement